Nucleus is far from their biggest client and the only reason they are losing them is because of James Hay's partnership agreement with FNZ. A lot of Bravura's blue chips renewed with them in 2021 - unfortunate circumstance regarding nucleus but definitely not the end. Nucleus is also still using Bravura tech for quite some time as the migration plans are developed.
But yes a takeover offer could potentially be on the cards in the next 6 months.
- Forums
- ASX - By Stock
- Ann: CFO Transition
BVS
bravura solutions limited.
Add to My Watchlist
0.00%
!
$2.24

Nucleus is far from their biggest client and the only reason...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
0.000(0.00%) |
Mkt cap ! $1.006B |
Open | High | Low | Value | Volume |
$2.22 | $2.30 | $2.20 | $1.743M | 777.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 16863 | $2.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.25 | 98800 | 43 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 15169 | 2.240 |
7 | 9224 | 2.230 |
10 | 55140 | 2.220 |
6 | 47110 | 2.210 |
7 | 24450 | 2.200 |
Price($) | Vol. | No. |
---|---|---|
2.250 | 109359 | 48 |
2.260 | 34423 | 8 |
2.270 | 71288 | 7 |
2.280 | 9672 | 5 |
2.290 | 171332 | 4 |
Last trade - 15.55pm 18/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online